| __timestamp | Amneal Pharmaceuticals, Inc. | Travere Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 84615000 | 59644696 |
| Thursday, January 1, 2015 | 109679000 | 79541000 |
| Friday, January 1, 2016 | 118757000 | 98015000 |
| Sunday, January 1, 2017 | 109046000 | 103958000 |
| Monday, January 1, 2018 | 230435000 | 103654000 |
| Tuesday, January 1, 2019 | 289598000 | 128951000 |
| Wednesday, January 1, 2020 | 326727000 | 135799000 |
| Friday, January 1, 2021 | 365504000 | 149883000 |
| Saturday, January 1, 2022 | 399700000 | 220206000 |
| Sunday, January 1, 2023 | 429675000 | 265542000 |
Igniting the spark of knowledge
In the competitive landscape of pharmaceuticals, understanding financial trends is crucial. Over the past decade, Amneal Pharmaceuticals and Travere Therapeutics have shown distinct trajectories in their Selling, General, and Administrative (SG&A) expenses. From 2014 to 2023, Amneal's SG&A expenses surged by over 400%, reflecting strategic investments and expansion efforts. In contrast, Travere's expenses grew by approximately 345%, indicating a steady yet significant increase.
Amneal's expenses jumped from 8% of their 2023 value in 2014 to nearly 100% in 2023, showcasing aggressive growth strategies. Meanwhile, Travere's expenses, starting at 6% of their 2023 value, highlight a more measured approach. This divergence underscores differing business models and market strategies.
These trends offer insights into each company's operational focus and market positioning, providing valuable context for investors and industry analysts alike.
AbbVie Inc. or Travere Therapeutics, Inc.: Who Manages SG&A Costs Better?
Cost Management Insights: SG&A Expenses for Walgreens Boots Alliance, Inc. and Amneal Pharmaceuticals, Inc.
Operational Costs Compared: SG&A Analysis of Jazz Pharmaceuticals plc and Travere Therapeutics, Inc.
Operational Costs Compared: SG&A Analysis of Pharming Group N.V. and Amneal Pharmaceuticals, Inc.
Comparing SG&A Expenses: Grifols, S.A. vs Travere Therapeutics, Inc. Trends and Insights
Who Optimizes SG&A Costs Better? Verona Pharma plc or Amneal Pharmaceuticals, Inc.
Operational Costs Compared: SG&A Analysis of Amneal Pharmaceuticals, Inc. and Merus N.V.
Who Optimizes SG&A Costs Better? Amneal Pharmaceuticals, Inc. or MannKind Corporation
Who Generates Higher Gross Profit? Amneal Pharmaceuticals, Inc. or Travere Therapeutics, Inc.
Rhythm Pharmaceuticals, Inc. or Travere Therapeutics, Inc.: Who Manages SG&A Costs Better?
Operational Costs Compared: SG&A Analysis of Dynavax Technologies Corporation and Travere Therapeutics, Inc.
Taro Pharmaceutical Industries Ltd. or Travere Therapeutics, Inc.: Who Manages SG&A Costs Better?